My research tries to identify why very preterm newborns are at high risk for brain damage. My goal is to identify exposures whose elimination or minimization might reduce the risk for this brain damage and its consequences. I had been the principal investigator of the 14-center ELGAN (Extremely Low Gestational Age Newborns) study, a prospective epidemiologic study of 1,500 infants born before the 28th week of gestation.

The ELGAN investigators seek to identify changes that occur before the brain ultrasound abnormalities that predict motor, cognitive, perceptual and behavior dysfunctions in these children. Much of this study relies on biomarkers measured in the placenta, umbilical cord and blood. Each of the proteins assessed has a role in inflammation, which is linked to oligodendrocyte damage and/or dysfunction or to processes that ameliorate damage/dysfunction.

By identifying biomarkers that indicate increased risk of cerebral damage, the ELGAN study should enable researchers to better design clinical trials of measures to reduce the occurrence of early brain damage and later developmental disabilities.



Alan Leviton received his MD from SUNY-Health Sciences Center at Brooklyn, College of Medicine. He trained in medicine at Kings County Hospital, Brooklyn, NY, in neurology at the Barnes Hospital/Washington University program in St. Louis, MO in neuropathology at Children's Hospital, and in epidemiology at Harvard School of Public Health.


Publications powered by Harvard Catalyst Profiles

  1. Prenatal tobacco smoke exposure and neurological impairment at 10 years of age among children born extremely preterm: a prospective cohort. BJOG. 2021 Mar 07. View abstract
  2. Identifying cerebral palsy phenotypes objectively. Dev Med Child Neurol. 2020 09; 62(9):1006. View abstract
  3. Histologic chorioamnionitis and risk of neurodevelopmental impairment at age 10 years among extremely preterm infants born before 28 weeks of gestation. Am J Obstet Gynecol. 2020 11; 223(5):745.e1-745.e10. View abstract
  4. Neonatal white matter damage and the fetal inflammatory response. Semin Fetal Neonatal Med. 2020 08; 25(4):101111. View abstract
  5. Neurocognitive and social-communicative function of children born very preterm at 10 years of age: Associations with microorganisms recovered from the placenta parenchyma. J Perinatol. 2020 02; 40(2):306-315. View abstract
  6. Characteristics of Future Models of Integrated Outpatient Care. Healthcare (Basel). 2019 Apr 27; 7(2). View abstract
  7. Antecedents of epilepsy and seizures among children born at extremely low gestational age. J Perinatol. 2019 06; 39(6):774-783. View abstract
  8. Socioeconomic status and early blood concentrations of inflammation-related and neurotrophic proteins among extremely preterm newborns. PLoS One. 2019; 14(3):e0214154. View abstract
  9. Early Postnatal IGF-1 and IGFBP-1 Blood Levels in Extremely Preterm Infants: Relationships with Indicators of Placental Insufficiency and with Systemic Inflammation. Am J Perinatol. 2019 12; 36(14):1442-1452. View abstract
  10. Neurocognitive function of 10-year-old multiples born less than 28 weeks of gestational age. J Perinatol. 2019 02; 39(2):237-247. View abstract
  11. Antecedents of Obesity Among Children Born Extremely Preterm. Pediatrics. 2018 11; 142(5). View abstract
  12. Caring electronically for young outpatients who have epilepsy. Epilepsy Behav. 2018 10; 87:226-232. View abstract
  13. Executive Dysfunction Early Postnatal Biomarkers among Children Born Extremely Preterm. J Neuroimmune Pharmacol. 2019 06; 14(2):188-199. View abstract
  14. Risk factors for chronic lung disease and asthma differ among children born extremely preterm. Pediatr Pulmonol. 2018 11; 53(11):1533-1540. View abstract
  15. Biases Inherent in Studies of Coffee Consumption in Early Pregnancy and the Risks of Subsequent Events. Nutrients. 2018 Aug 23; 10(9). View abstract
  16. Behavioural dysfunctions of 10-year-old children born extremely preterm associated with corticotropin-releasing hormone expression in the placenta. Acta Paediatr. 2018 11; 107(11):1932-1936. View abstract
  17. Neurocognitive and Health Correlates of Overweight and Obesity among Ten-Year-Old Children Born Extremely Preterm. J Pediatr. 2018 09; 200:84-90.e4. View abstract
  18. Elevated protein concentrations in newborn blood and the risks of autism spectrum disorder, and of social impairment, at age 10 years among infants born before the 28th week of gestation. Transl Psychiatry. 2018 06 08; 8(1):115. View abstract
  19. Accuracy of the Bayley-II mental development index at 2 years as a predictor of cognitive impairment at school age among children born extremely preterm. J Perinatol. 2018 07; 38(7):908-916. View abstract
  20. Cognitive Development and Quality of Life Associated With BPD in 10-Year-Olds Born Preterm. Pediatrics. 2018 06; 141(6). View abstract
  21. The risk of neurodevelopmental disorders at age 10?years associated with blood concentrations of interleukins 4 and 10 during the first postnatal month of children born extremely preterm. Cytokine. 2018 10; 110:181-188. View abstract
  22. Socioemotional dysfunctions at age 10?years in extremely preterm newborns with late-onset bacteremia. Early Hum Dev. 2018 06; 121:1-7. View abstract
  23. Can a collaborative healthcare network improve the care of people with epilepsy? Epilepsy Behav. 2018 05; 82:189-193. View abstract
  24. Antenatal and neonatal antecedents of learning limitations in 10-year old children born extremely preterm. Early Hum Dev. 2018 03; 118:8-14. View abstract
  25. Neonatal systemic inflammation and the risk of low scores on measures of reading and mathematics achievement at age 10 years among children born extremely preterm. Int J Dev Neurosci. 2018 May; 66:45-53. View abstract
  26. Circulating biomarkers in extremely preterm infants associated with ultrasound indicators of brain damage. Eur J Paediatr Neurol. 2018 May; 22(3):440-450. View abstract
  27. Antenatal and Neonatal Antecedents of Executive Dysfunctions in Extremely Preterm Children. J Child Neurol. 2018 03; 33(3):198-208. View abstract
  28. Are Extremely Low Gestational Age Newborns Born to Obese Women at Increased Risk of Cerebral Palsy at 2 Years? J Child Neurol. 2018 03; 33(3):216-224. View abstract
  29. Hand Preference and Cognitive, Motor, and Behavioral Functioning in 10-Year-Old Extremely Preterm Children. J Pediatr. 2018 04; 195:279-282.e3. View abstract
  30. Elevations of inflammatory proteins in neonatal blood are associated with obesity and overweight among 2-year-old children born extremely premature. Pediatr Res. 2018 06; 83(6):1110-1119. View abstract
  31. Antecedents of Screening Positive for Attention Deficit Hyperactivity Disorder in Ten-Year-Old Children Born Extremely Preterm. Pediatr Neurol. 2018 04; 81:25-30. View abstract
  32. Systemic Inflammation-Associated Proteins and Retinopathy of Prematurity in Infants Born Before the 28th Week of Gestation. Invest Ophthalmol Vis Sci. 2017 12 01; 58(14):6419-6428. View abstract
  33. Social Responsiveness Scale Assessment of the Preterm Behavioral Phenotype in 10-Year-Olds Born Extremely Preterm. J Dev Behav Pediatr. 2017 Nov/Dec; 38(9):697-705. View abstract
  34. Neurodevelopment at Age 10 Years of Children Born <28 Weeks With Fetal Growth Restriction. Pediatrics. 2017 Nov; 140(5). View abstract
  35. Maternal obesity and attention-related symptoms in the preterm offspring. Early Hum Dev. 2017 12; 115:9-15. View abstract
  36. Hypoxia-ischemia is not an antecedent of most preterm brain damage: the illusion of validity. Dev Med Child Neurol. 2018 02; 60(2):120-125. View abstract
  37. Cognitive functioning at the age of 10?years among children born extremely preterm: a latent profile approach. Pediatr Res. 2017 Oct; 82(4):614-619. View abstract
  38. Both antenatal and postnatal inflammation contribute information about the risk of brain damage in extremely preterm newborns. Pediatr Res. 2017 Oct; 82(4):691-696. View abstract
  39. Cumulative Incidence of Seizures and Epilepsy in Ten-Year-Old Children Born Before 28 Weeks' Gestation. Pediatr Neurol. 2017 Aug; 73:13-19. View abstract
  40. Neurocognitive Outcomes at 10 Years of Age in Extremely Preterm Newborns with Late-Onset Bacteremia. J Pediatr. 2017 08; 187:43-49.e1. View abstract
  41. Observer variability identifying attention deficit/hyperactivity disorder in 10-year-old children born extremely preterm. Acta Paediatr. 2017 Aug; 106(8):1317-1322. View abstract
  42. Antecedents and early correlates of high and low concentrations of angiogenic proteins in extremely preterm newborns. Clin Chim Acta. 2017 Aug; 471:1-5. View abstract
  43. Neurocognitive Correlates of Attention-Deficit Hyperactivity Disorder Symptoms in Children Born at Extremely Low Gestational Age. J Dev Behav Pediatr. 2017 May; 38(4):249-259. View abstract
  44. Systemic Inflammation during the First Postnatal Month and the Risk of Attention Deficit Hyperactivity Disorder Characteristics among 10 year-old Children Born Extremely Preterm. J Neuroimmune Pharmacol. 2017 09; 12(3):531-543. View abstract
  45. Newborn blood gas derangements of children born extremely preterm and neurocognitive dysfunctions at age 10 years. Respir Physiol Neurobiol. 2017 08; 242:66-72. View abstract
  46. Antecedents and correlates of blood concentrations of neurotrophic growth factors in very preterm newborns. Cytokine. 2017 06; 94:21-28. View abstract
  47. The Relationship of Maternal Prepregnancy Body Mass Index and Pregnancy Weight Gain to Neurocognitive Function at Age 10 Years among Children Born Extremely Preterm. J Pediatr. 2017 08; 187:50-57.e3. View abstract
  48. Postnatal systemic inflammation and neuro-ophthalmologic dysfunctions in extremely low gestational age children. Acta Paediatr. 2017 Mar; 106(3):454-457. View abstract
  49. Early postnatal illness severity scores predict neurodevelopmental impairments at 10 years of age in children born extremely preterm. J Perinatol. 2017 05; 37(5):606-614. View abstract
  50. Extremely low gestational age and very low birthweight for gestational age are risk factors for autism spectrum disorder in a large cohort study of 10-year-old children born at 23-27 weeks' gestation. Am J Obstet Gynecol. 2017 Mar; 216(3):304.e1-304.e16. View abstract
  51. Antenatal glucocorticoids and neonatal inflammation-associated proteins. Cytokine. 2016 12; 88:199-208. View abstract
  52. Predictive Validity of the Modified Checklist for Autism in Toddlers (M-CHAT) Born Very Preterm. J Pediatr. 2016 Nov; 178:101-107.e2. View abstract
  53. Prevalence and associated features of autism spectrum disorder in extremely low gestational age newborns at age 10 years. Autism Res. 2017 Feb; 10(2):224-232. View abstract
  54. The antecedents and correlates of necrotizing enterocolitis and spontaneous intestinal perforation among infants born before the 28th week of gestation. J Neonatal Perinatal Med. 2016 May 19; 9(2):159-70. View abstract
  55. Systemic endogenous erythropoietin and associated disorders in extremely preterm newborns. Arch Dis Child Fetal Neonatal Ed. 2016 Sep; 101(5):F458-63. View abstract
  56. Duration of Systemic Inflammation in the First Postnatal Month Among Infants Born Before the 28th Week of Gestation. Inflammation. 2016 Apr; 39(2):672-7. View abstract
  57. Neurocognitive and Academic Outcomes at Age 10 Years of Extremely Preterm Newborns. Pediatrics. 2016 Apr; 137(4). View abstract
  58. Girls and Boys Born before 28 Weeks Gestation: Risks of Cognitive, Behavioral, and Neurologic Outcomes at Age 10 Years. J Pediatr. 2016 Jun; 173:69-75.e1. View abstract
  59. Reply to Commentary by Strandvik: 'The development of infants born to obese mothers might be related to omega-3 fatty acid status'. Acta Paediatr. 2016 Mar; 105(3):e93. View abstract
  60. Systemic inflammation on postnatal days 21 and 28 and indicators of brain dysfunction 2years later among children born before the 28th week of gestation. Early Hum Dev. 2016 Feb; 93:25-32. View abstract
  61. Antecedents of inflammation biomarkers in preterm newborns on days 21 and 28. Acta Paediatr. 2016 Mar; 105(3):274-80. View abstract
  62. The Development of Extremely Preterm Infants Born to Women Who Had Genitourinary Infections During Pregnancy. Am J Epidemiol. 2016 Jan 01; 183(1):28-35. View abstract
  63. Brain disorders associated with corticotropin-releasing hormone expression in the placenta among children born before the 28th week of gestation. Acta Paediatr. 2016 Jan; 105(1):e7-11. View abstract
  64. Weight Status in the First 2 Years of Life and Neurodevelopmental Impairment in Extremely Low Gestational Age Newborns. J Pediatr. 2016 Jan; 168:30-35.e2. View abstract
  65. The role of systemic inflammation linking maternal BMI to neurodevelopment in children. Pediatr Res. 2016 Jan; 79(1-1):3-12. View abstract
  66. Strabismus at Age 2 Years in Children Born Before 28 Weeks' Gestation: Antecedents and Correlates. J Child Neurol. 2016 Mar; 31(4):451-60. View abstract
  67. Antecedents of the child behavior checklist-dysregulation profile in children born extremely preterm. J Am Acad Child Adolesc Psychiatry. 2015 Oct; 54(10):816-23. View abstract
  68. Maternal obesity and development of the preterm newborn at 2 years. Acta Paediatr. 2015 Sep; 104(9):900-3. View abstract
  69. Systems approach to the study of brain damage in the very preterm newborn. Front Syst Neurosci. 2015; 9:58. View abstract
  70. Elevated endogenous erythropoietin concentrations are associated with increased risk of brain damage in extremely preterm neonates. PLoS One. 2015; 10(3):e0115083. View abstract
  71. Systems Epidemiology: What's in a Name? Online J Public Health Inform. 2014; 6(3):e198. View abstract
  72. Are preterm newborns who have relative hyperthyrotropinemia at increased risk of brain damage? J Pediatr Endocrinol Metab. 2014 Nov; 27(11-12):1077-88. View abstract
  73. Prethreshold retinopathy in premature infants with intrauterine growth restriction. Acta Paediatr. 2015 Jan; 104(1):27-31. View abstract
  74. The breadth and type of systemic inflammation and the risk of adverse neurological outcomes in extremely low gestation newborns. Pediatr Neurol. 2015 Jan; 52(1):42-8. View abstract
  75. Antecedents and correlates of visual field deficits in children born extremely preterm. Eur J Paediatr Neurol. 2015 Jan; 19(1):56-63. View abstract
  76. Antenatal and early postnatal antecedents of parent-reported attention problems at 2 years of age. J Pediatr. 2015 Jan; 166(1):20-5. View abstract
  77. Systemic inflammation in the extremely low gestational age newborn following maternal genitourinary infections. Am J Reprod Immunol. 2015 Feb; 73(2):162-74. View abstract
  78. The relationship between TSH and systemic inflammation in extremely preterm newborns. Endocrine. 2015 Mar; 48(2):595-602. View abstract
  79. Endogenous erythropoietin varies significantly with inflammation-related proteins in extremely premature newborns. Cytokine. 2014 Sep; 69(1):22-8. View abstract
  80. Retinopathy of prematurity and brain damage in the very preterm newborn. J AAPOS. 2014 Jun; 18(3):241-7. View abstract
  81. Early blood gas predictors of bronchopulmonary dysplasia in extremely low gestational age newborns. Int J Pediatr. 2014; 2014:210218. View abstract
  82. Elevated blood levels of inflammation-related proteins are associated with an attention problem at age 24 mo in extremely preterm infants. Pediatr Res. 2014 Jun; 75(6):781-7. View abstract
  83. Systemic inflammation and cerebral palsy risk in extremely preterm infants. J Child Neurol. 2014 Dec; 29(12):1692-8. View abstract
  84. Impaired visual fixation at the age of 2 years in children born before the twenty-eighth week of gestation. Antecedents and correlates in the multicenter ELGAN study. Pediatr Neurol. 2014 Jul; 51(1):36-42. View abstract
  85. Lenticulostriate vasculopathy in extremely low gestational age newborns: Inter-rater variability of cranial ultrasound readings, antecedents and postnatal characteristics. J Pediatr Neurol. 2014; 12(4):183-193. View abstract
  86. Development and implementation of a quality improvement curriculum for child neurology residents: lessons learned. Pediatr Neurol. 2014 May; 50(5):452-7. View abstract
  87. Intermittent or sustained systemic inflammation and the preterm brain. Pediatr Res. 2014 Mar; 75(3):376-80. View abstract
  88. Risk factors and correlates of neonatal growth velocity in extremely low gestational age newborns: the ELGAN Study. Neonatology. 2013; 104(4):298-304. View abstract
  89. Comparison of frozen and unfrozen blood spots for gene expression studies. J Pediatr. 2014 Jan; 164(1):189-191.e1. View abstract
  90. Social-emotional delays at 2 years in extremely low gestational age survivors: correlates of impaired orientation/engagement and emotional regulation. Early Hum Dev. 2013 Dec; 89(12):925-30. View abstract
  91. Is maternal obesity associated with sustained inflammation in extremely low gestational age newborns? Early Hum Dev. 2013 Dec; 89(12):949-55. View abstract
  92. Perinatal systemic inflammatory responses of growth-restricted preterm newborns. Acta Paediatr. 2013 Oct; 102(10):e439-42. View abstract
  93. Antecedents of perinatal cerebral white matter damage with and without intraventricular hemorrhage in very preterm newborns. Pediatr Neurol. 2013 Aug; 49(2):88-96. View abstract
  94. Candidate gene analysis: severe intraventricular hemorrhage in inborn preterm neonates. J Pediatr. 2013 Nov; 163(5):1503-6.e1. View abstract
  95. Visual aids to medical data and computational diagnostics: new frontiers in pediatric neurology. Epilepsy Behav. 2013 Aug; 28(2):258-60. View abstract
  96. Early nutrition and weight gain in preterm newborns and the risk of retinopathy of prematurity. PLoS One. 2013; 8(5):e64325. View abstract
  97. Clinical practice guidelines and practice parameters for the child neurologist. J Child Neurol. 2013 Jul; 28(7):917-25. View abstract
  98. Should readmission within 30 days after discharge of children hospitalized for a neurologic disorder be considered a quality assurance failure? J Child Neurol. 2013 Jun; 28(6):758-61. View abstract
  99. Pregnancy disorders appear to modify the risk for retinopathy of prematurity associated with neonatal hyperoxemia and bacteremia. J Matern Fetal Neonatal Med. 2013 May; 26(8):811-8. View abstract
  100. Inflammation-initiating illnesses, inflammation-related proteins, and cognitive impairment in extremely preterm infants. Brain Behav Immun. 2013 Mar; 29:104-112. View abstract
  101. Two-hit model of brain damage in the very preterm newborn: small for gestational age and postnatal systemic inflammation. Pediatr Res. 2013 Mar; 73(3):362-70. View abstract
  102. Systemic inflammation associated with mechanical ventilation among extremely preterm infants. Cytokine. 2013 Jan; 61(1):315-22. View abstract
  103. Systemic inflammation, intraventricular hemorrhage, and white matter injury. J Child Neurol. 2013 Dec; 28(12):1637-45. View abstract
  104. Systemic inflammation associated with severe intestinal injury in extremely low gestational age newborns. Fetal Pediatr Pathol. 2013 Jun; 32(3):222-34. View abstract
  105. Why the term neonatal encephalopathy should be preferred over neonatal hypoxic-ischemic encephalopathy. Am J Obstet Gynecol. 2013 Mar; 208(3):176-80. View abstract
  106. Brain damage in preterm newborns and maternal medication: the ELGAN Study. Am J Obstet Gynecol. 2012 Sep; 207(3):192.e1-9. View abstract
  107. Birth weight- and fetal weight-growth restriction: impact on neurodevelopment. Early Hum Dev. 2012 Sep; 88(9):765-71. View abstract
  108. Antenatal antecedents of cognitive impairment at 24 months in extremely low gestational age newborns. Pediatrics. 2012 Mar; 129(3):494-502. View abstract
  109. Intraventricular hemorrhage and developmental outcomes at 24 months of age in extremely preterm infants. J Child Neurol. 2012 Jan; 27(1):22-9. View abstract
  110. Fetal-placental inflammation, but not adrenal activation, is associated with extreme preterm delivery. Am J Obstet Gynecol. 2012 Mar; 206(3):236.e1-8. View abstract
  111. Systemic responses of preterm newborns with presumed or documented bacteraemia. Acta Paediatr. 2012 Apr; 101(4):355-9. View abstract
  112. Neonatal bacteremia and retinopathy of prematurity: the ELGAN study. Arch Ophthalmol. 2011 Dec; 129(12):1555-63. View abstract
  113. Relationships among the concentrations of 25 inflammation-associated proteins during the first postnatal weeks in the blood of infants born before the 28th week of gestation. Cytokine. 2012 Jan; 57(1):182-90. View abstract
  114. Elevated concentrations of inflammation-related proteins in postnatal blood predict severe developmental delay at 2 years of age in extremely preterm infants. J Pediatr. 2012 Mar; 160(3):395-401.e4. View abstract
  115. What is quality improvement and why should child neurologists care? J Child Neurol. 2012 Feb; 27(2):251-7. View abstract
  116. Patterns of blood protein concentrations of ELGANs classified by three patterns of respiratory disease in the first 2 postnatal weeks. Pediatr Res. 2011 Sep; 70(3):292-6. View abstract
  117. Placenta microbiology and histology and the risk for severe retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2011 Sep 01; 52(10):7052-8. View abstract
  118. Blood protein concentrations in the first two postnatal weeks associated with early postnatal blood gas derangements among infants born before the 28th week of gestation. The ELGAN Study. Cytokine. 2011 Nov; 56(2):392-8. View abstract
  119. Persistence after birth of systemic inflammation associated with umbilical cord inflammation. J Reprod Immunol. 2011 Aug; 90(2):235-43. View abstract
  120. Quality improvement specific for child neurology. J Child Neurol. 2011 Jun; 26(6):673-4. View abstract
  121. Cluster analysis of placental inflammatory proteins can distinguish preeclampsia from preterm labor and premature membrane rupture in singleton deliveries less than 28 weeks of gestation. Am J Reprod Immunol. 2011 Dec; 66(6):488-94. View abstract
  122. Blood protein concentrations in the first two postnatal weeks that predict bronchopulmonary dysplasia among infants born before the 28th week of gestation. Pediatr Res. 2011 Apr; 69(4):347-53. View abstract
  123. The Modified Checklist for Autism in Toddlers in extremely low gestational age newborns: individual items associated with motor, cognitive, vision and hearing limitations. Paediatr Perinat Epidemiol. 2011 Jul; 25(4):366-76. View abstract
  124. Blood protein profiles of infants born before 28 weeks differ by pregnancy complication. Am J Obstet Gynecol. 2011 May; 204(5):418.e1-418.e12. View abstract
  125. Early postnatal blood concentrations of inflammation-related proteins and microcephaly two years later in infants born before the 28th post-menstrual week. Early Hum Dev. 2011 May; 87(5):325-30. View abstract
  126. Early postnatal hypotension is not associated with indicators of white matter damage or cerebral palsy in extremely low gestational age newborns. J Perinatol. 2011 Aug; 31(8):524-34. View abstract
  127. Maternal microbe-specific modulation of inflammatory response in extremely low-gestational-age newborns. mBio. 2011 Jan 18; 2(1):e00280-10. View abstract
  128. The relationship between early concentrations of 25 blood proteins and cerebral white matter injury in preterm newborns: the ELGAN study. J Pediatr. 2011 Jun; 158(6):897-903.e1-5. View abstract
  129. Relationship Between Neonatal Blood Protein Concentrations and Placenta Histologic Characteristics in Extremely Low GA Newborns. Pediatr Res. 2011 Jan; 69(1):68-73. View abstract
  130. Early postnatal hypotension and developmental delay at 24 months of age among extremely low gestational age newborns. Arch Dis Child Fetal Neonatal Ed. 2011 Sep; 96(5):F321-8. View abstract
  131. The challenge of causal inference. Ann Neurol. 2010 Nov; 68(5):770. View abstract
  132. Inflammation-related proteins in the blood of extremely low gestational age newborns. The contribution of inflammation to the appearance of developmental regulation. Cytokine. 2011 Jan; 53(1):66-73. View abstract
  133. Reader variability in the use of diagnostic terms to describe white matter lesions seen on cranial scans of severely premature infants: the ELGAN study. J Clin Ultrasound. 2010 Oct; 38(8):409-19. View abstract
  134. The clustering of disorders in infants born before the 28th week of gestation. Acta Paediatr. 2010 Dec; 99(12):1795-800. View abstract
  135. Early blood gas abnormalities and the preterm brain. Am J Epidemiol. 2010 Oct 15; 172(8):907-16. View abstract
  136. Does bronchopulmonary dysplasia contribute to the occurrence of cerebral palsy among infants born before 28 weeks of gestation? Arch Dis Child Fetal Neonatal Ed. 2011 Jan; 96(1):F20-9. View abstract
  137. Early cranial ultrasound lesions predict microcephaly at age 2 years in preterm infants. J Child Neurol. 2011 Feb; 26(2):188-94. View abstract
  138. Presumed and definite bacteremia in extremely low gestational age newborns. Acta Paediatr. 2011 Jan; 100(1):36-41. View abstract
  139. Antecedents of chronic lung disease following three patterns of early respiratory disease in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2011 Mar; 96(2):F114-20. View abstract
  140. Antenatal antecedents of a small head circumference at age 24-months post-term equivalent in a sample of infants born before the 28th post-menstrual week. Early Hum Dev. 2010 Aug; 86(8):515-21. View abstract
  141. Blood gases and retinopathy of prematurity: the ELGAN Study. Neonatology. 2011; 99(2):104-11. View abstract
  142. Fears and promises of comparative effectiveness research. Acta Paediatr. 2010 Sep; 99(9):1311-3. View abstract
  143. Neurodevelopment of extremely preterm infants who had necrotizing enterocolitis with or without late bacteremia. J Pediatr. 2010 Nov; 157(5):751-6.e1. View abstract
  144. A review of the epidemiologic evidence concerning the reproductive health effects of caffeine consumption: a 2000-2009 update. Food Chem Toxicol. 2010 Oct; 48(10):2549-76. View abstract
  145. Factors associated with small head circumference at birth among infants born before the 28th week. Am J Obstet Gynecol. 2010 Aug; 203(2):138.e1-8. View abstract
  146. Mechanisms of injury to white matter adjacent to a large intraventricular hemorrhage in the preterm brain. J Clin Ultrasound. 2010 Jun; 38(5):254-8. View abstract
  147. Microbiologic and histologic characteristics of the extremely preterm infant's placenta predict white matter damage and later cerebral palsy. the ELGAN study. Pediatr Res. 2010 Jan; 67(1):95-101. View abstract
  148. Endoplasmic reticulum stress, inflammation, and perinatal brain damage. Pediatr Res. 2009 Nov; 66(5):487-94. View abstract
  149. Interinstitutional variation in prediction of death by SNAP-II and SNAPPE-II among extremely preterm infants. Pediatrics. 2009 Nov; 124(5):e1001-6. View abstract
  150. The ELGAN study of the brain and related disorders in extremely low gestational age newborns. Early Hum Dev. 2009 Nov; 85(11):719-25. View abstract
  151. Maternal antenatal complications and the risk of neonatal cerebral white matter damage and later cerebral palsy in children born at an extremely low gestational age. Am J Epidemiol. 2009 Oct 01; 170(7):819-28. View abstract
  152. Fetal growth restriction and chronic lung disease among infants born before the 28th week of gestation. Pediatrics. 2009 Sep; 124(3):e450-8. View abstract
  153. SNAP-II and SNAPPE-II and the risk of structural and functional brain disorders in extremely low gestational age newborns: the ELGAN study. Neonatology. 2010; 97(2):71-82. View abstract
  154. Nutritional practices and growth velocity in the first month of life in extremely premature infants. Pediatrics. 2009 Aug; 124(2):649-57. View abstract
  155. Chronic lung disease and developmental delay at 2 years of age in children born before 28 weeks' gestation. Pediatrics. 2009 Aug; 124(2):637-48. View abstract
  156. Developmental correlates of head circumference at birth and two years in a cohort of extremely low gestational age newborns. J Pediatr. 2009 Sep; 155(3):344-9.e1-3. View abstract
  157. Perinatal correlates of Ureaplasma urealyticum in placenta parenchyma of singleton pregnancies that end before 28 weeks of gestation. Pediatrics. 2009 May; 123(5):1329-36. View abstract
  158. Patterns of respiratory disease during the first 2 postnatal weeks in extremely premature infants. Pediatrics. 2009 Apr; 123(4):1124-31. View abstract
  159. Positive screening on the Modified Checklist for Autism in Toddlers (M-CHAT) in extremely low gestational age newborns. J Pediatr. 2009 Apr; 154(4):535-540.e1. View abstract
  160. Cranial ultrasound lesions in the NICU predict cerebral palsy at age 2 years in children born at extremely low gestational age. J Child Neurol. 2009 Jan; 24(1):63-72. View abstract
  161. Even tension-type headaches doesn't sound right. Acta Paediatr. 2008 Oct; 97(10):1344-5. View abstract
  162. Neonatal cranial ultrasound lesions and developmental delays at 2 years of age among extremely low gestational age children. Pediatrics. 2008 Sep; 122(3):e662-9. View abstract
  163. Pregnancy disorders that lead to delivery before the 28th week of gestation: an epidemiologic approach to classification. Am J Epidemiol. 2008 Nov 01; 168(9):980-9. View abstract
  164. An algorithm for identifying and classifying cerebral palsy in young children. J Pediatr. 2008 Oct; 153(4):466-72. View abstract
  165. Histological characteristics of singleton placentas delivered before the 28th week of gestation. Pathology. 2008 Jun; 40(4):372-6. View abstract
  166. Colonization of second-trimester placenta parenchyma. Am J Obstet Gynecol. 2008 Jul; 199(1):52.e1-52.e10. View abstract
  167. Characterization of chorioamnionitis in 2nd-trimester C-section placentas and correlation with microorganism recovery from subamniotic tissues. Pediatr Dev Pathol. 2008 Jan-Feb; 11(1):15-22. View abstract
  168. Detection of bacteria in placental tissues obtained from extremely low gestational age neonates. Am J Obstet Gynecol. 2008 Jan; 198(1):110.e1-7. View abstract
  169. Neuregulin-1: a potential endogenous protector in perinatal brain white matter damage. Neonatology. 2008; 93(3):182-7. View abstract
  170. Observer variability assessing US scans of the preterm brain: the ELGAN study. Pediatr Radiol. 2007 Dec; 37(12):1201-8. View abstract
  171. Neuronal damage accompanies perinatal white-matter damage. Trends Neurosci. 2007 Sep; 30(9):473-8. View abstract
  172. Intraventricular haemorrhage grading scheme: time to abandon? Acta Paediatr. 2007 Sep; 96(9):1254-6. View abstract
  173. Reference weights for placentas delivered before the 28th week of gestation. Placenta. 2007 Oct; 28(10):987-90. View abstract
  174. Motivated reasoning. Acta Paediatr. 2007 Jul; 96(7):949. View abstract
  175. Factors associated with treatment for hypotension in extremely low gestational age newborns during the first postnatal week. Pediatrics. 2007 Feb; 119(2):273-80. View abstract
  176. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl. 2007 Feb; 109:8-14. View abstract
  177. Perturbation of gene expression of the chromatin remodeling pathway in premature newborns at risk for bronchopulmonary dysplasia. Genome Biol. 2007; 8(10):R210. View abstract
  178. Perinatal brain damage causation. Dev Neurosci. 2007; 29(4-5):280-8. View abstract
  179. The discourteous reviewer. Paediatr Perinat Epidemiol. 2007 Jan; 21(1):2-4. View abstract
  180. Neuroimaging and the prediction of outcomes in preterm infants. N Engl J Med. 2006 Aug 17; 355(7):727-9. View abstract
  181. Periventricular leukomalacia might not specifically affect cortical magnetoencephalographic response to biological motion. Ann Neurol. 2006 Aug; 60(2):269; author reply 269-70. View abstract
  182. Thymus involution and cerebral white matter damage in extremely low gestational age neonates. Biol Neonate. 2006; 90(4):252-7. View abstract
  183. Hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med. 2006 Apr 13; 354(15):1643-5; author reply 1643-5. View abstract
  184. Inflammation, brain damage and visual dysfunction in preterm infants. Semin Fetal Neonatal Med. 2006 Oct; 11(5):363-8. View abstract
  185. The adaptive immune response in neonatal cerebral white matter damage. Ann Neurol. 2005 Dec; 58(6):821-8. View abstract
  186. Video and CD-ROM as a training tool for performing neurologic examinations of 1-year-old children in a multicenter epidemiologic study. J Child Neurol. 2005 Oct; 20(10):829-31. View abstract
  187. Proposed definition and classification of cerebral palsy, April 2005. Dev Med Child Neurol. 2005 Aug; 47(8):571-6. View abstract
  188. Lung and brain damage in preterm newborns, and their association with gestational age, prematurity subgroup, infection/inflammation and long term outcome. BJOG. 2005 Mar; 112 Suppl 1:4-9. View abstract
  189. Antenatal glucocorticoids increase early total thyroxine levels in premature infants. Biol Neonate. 2005; 87(4):273-80. View abstract
  190. The wealth of information conveyed by gestational age. J Pediatr. 2005 Jan; 146(1):123-7. View abstract
  191. Preconditioning and the developing brain. Semin Perinatol. 2004 Dec; 28(6):389-95. View abstract
  192. Fetal vasculitis in preterm newborns: interrelationships, modifiers, and antecedents. Placenta. 2004 Nov; 25(10):788-96. View abstract
  193. Inflammatory brain damage in preterm newborns--dry numbers, wet lab, and causal inferences. Early Hum Dev. 2004 Aug; 79(1):1-15. View abstract
  194. Lung and brain damage in preterm newborns. Are they related? How? Why? Biol Neonate. 2004; 85(4):305-13. View abstract
  195. Prognostic limitations of the Daumas-Duport grading scheme in infratentorial neuroglial tumors in children. Pediatr Dev Pathol. 2004 Mar-Apr; 7(2):138-47. View abstract
  196. Coagulation, inflammation, and the risk of neonatal white matter damage. Pediatr Res. 2004 Apr; 55(4):541-5. View abstract
  197. Biomarker epidemiology of cerebral palsy. Ann Neurol. 2004 Feb; 55(2):158-61. View abstract
  198. Bronchopulmonary dysplasia is not associated with ultrasound-defined cerebral white matter damage in preterm newborns. Pediatr Res. 2004 Feb; 55(2):319-25. View abstract
  199. Prolonged latency after preterm premature rupture of membranes: an evaluation of histologic condition and intracranial ultrasonic abnormality in the neonate born at <28 weeks of gestation. Am J Obstet Gynecol. 2003 Sep; 189(3):794-8. View abstract
  200. Antenatal mycoplasma infection, the fetal inflammatory response and cerebral white matter damage in very-low-birthweight infants. Paediatr Perinat Epidemiol. 2003 Jan; 17(1):49-57. View abstract
  201. Adult stroke and perinatal brain damage: like grandparent, like grandchild? Neuropediatrics. 2002 Dec; 33(6):281-7. View abstract
  202. Methodologic issues in epidemiologic studies of congenital microcephaly. Early Hum Dev. 2002 Oct; 69(1-2):91-105. View abstract
  203. Clinical and survival covariates of eight classes of childhood supratentorial neuroglial tumors. Cancer. 2002 Sep 15; 95(6):1302-10. View abstract
  204. A review of the literature relating caffeine consumption by women to their risk of reproductive hazards. Food Chem Toxicol. 2002 Sep; 40(9):1271-310. View abstract
  205. Neurological sequelae in in-vitro fertilisation babies. Lancet. 2002 Aug 31; 360(9334):718; author reply 719. View abstract
  206. Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants. J Pediatr. 2002 Feb; 140(2):171-6. View abstract
  207. Systemic hypotension and white-matter damage in preterm infants. Dev Med Child Neurol. 2002 Feb; 44(2):82-90. View abstract
  208. Perinatal infection, fetal inflammatory response, white matter damage, and cognitive limitations in children born preterm. Ment Retard Dev Disabil Res Rev. 2002; 8(1):46-50. View abstract
  209. Brain damage markers in children. Neurobiological and clinical aspects. Acta Paediatr. 2002; 91(1):9-13. View abstract
  210. Risk of cranial ultrasound abnormalities in very-low-birth-weight infants conceived with assisted reproductive techniques. J Perinatol. 2002 Jan; 22(1):37-45. View abstract
  211. Growth-restricted premature infants are at increased risk for low thyroxine. Early Hum Dev. 2001 Sep; 64(2):119-28. View abstract
  212. Broad-spectrum antibiotics in ORACLE. Lancet. 2001 Aug 11; 358(9280):502; author reply 503-4. View abstract
  213. Congenital microcephaly: phenotypic features in a consecutive sample of newborn infants. J Pediatr. 2001 Aug; 139(2):210-4. View abstract
  214. Do white cells matter in white matter damage? Trends Neurosci. 2001 Jun; 24(6):320-4. View abstract
  215. Topography of cerebral white-matter disease of prematurity studied prospectively in 1607 very-low-birthweight infants. J Child Neurol. 2001 Jun; 16(6):401-8. View abstract
  216. Is periventricular leukomalacia an axonopathy as well as an oligopathy? Pediatr Res. 2001 Apr; 49(4):453-7. View abstract
  217. Hypocarbia during the first 24 postnatal hours and white matter echolucencies in newborns < or = 28 weeks gestation. Pediatr Res. 2001 Mar; 49(3):388-93. View abstract
  218. Possible strategies to protect the preterm brain against the fetal inflammatory response. Dev Med Child Neurol Suppl. 2001 Mar; 86:18-20. View abstract
  219. Mediators of fetal inflammation in extremely low gestational age newborns. Cytokine. 2001 Feb 21; 13(4):234-9. View abstract
  220. Antenatal glucocorticoid treatment does not reduce chronic lung disease among surviving preterm infants. J Pediatr. 2001 Feb; 138(2):198-204. View abstract
  221. Reduced visual resolution acuity and cerebral white matter damage in very-low-birthweight infants. Dev Med Child Neurol. 2000 Dec; 42(12):809-15. View abstract
  222. Very low birthweight Infant's placenta and its relation to pregnancy and fetal characteristics. Pediatr Dev Pathol. 2000 Sep-Oct; 3(5):419-30. View abstract
  223. Very low birthweight placenta: clustering of morphologic characteristics. Pediatr Dev Pathol. 2000 Sep-Oct; 3(5):431-8. View abstract
  224. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network. Pediatrics. 2000 Jun; 105(6):1194-201. View abstract
  225. Sonographically detected subarachnoid hemorrhage: an independent predictor of neonatal posthemorrhagic hydrocephalus? Clin Imaging. 2000 May-Jun; 24(3):121-9. View abstract
  226. Brain damage in preterm newborns: biological response modification as a strategy to reduce disabilities. J Pediatr. 2000 Apr; 136(4):433-8. View abstract
  227. Role of the fetus in perinatal infection and neonatal brain damage. Curr Opin Pediatr. 2000 Apr; 12(2):99-104. View abstract
  228. Limitations of the World Health Organization classification of childhood supratentorial astrocytic tumors. Children Brain Tumor Consortium. Cancer. 2000 Mar 15; 88(6):1477-83. View abstract
  229. Definitive classes of childhood supratentorial neuroglial tumors. The Childhood Brain Tumor Consortium. Pediatr Dev Pathol. 2000 Mar-Apr; 3(2):126-39. View abstract
  230. Placental cytokine expression in preterm labour and the fetal inflammatory response. Cytokine. 2000 Feb; 12(2):176-7. View abstract
  231. What explains away the increased risk of histological chorioamnionitis in African-American mothers of very-low-birthweight infants? Developmental Epidemiology Network Investigators. Paediatr Perinat Epidemiol. 2000 Jan; 14(1):20-9. View abstract
  232. New research directions in neuroepidemiology. Epidemiol Rev. 2000; 22(1):18-23. View abstract
  233. Maternal infection, fetal inflammatory response, and brain damage in very low birth weight infants. Developmental Epidemiology Network Investigators. Pediatr Res. 1999 Nov; 46(5):566-75. View abstract
  234. Labor and delivery characteristics and risks of cranial ultrasonographic abnormalities among very-low-birth-weight infants. The Developmental Epidemiology Network Investigators. Am J Obstet Gynecol. 1999 Oct; 181(4):997-1006. View abstract
  235. Antenatal corticosteroids and cranial ultrasonographic abnormalities. Am J Obstet Gynecol. 1999 Oct; 181(4):1007-17. View abstract
  236. Brain damage in preterm newborns: might enhancement of developmentally regulated endogenous protection open a door for prevention? Pediatrics. 1999 Sep; 104(3 Pt 1):541-50. View abstract
  237. Hypothyroxinemia of prematurity and the risk of cerebral white matter damage. J Pediatr. 1999 Jun; 134(6):706-11. View abstract
  238. White matter disorders of prematurity: association with intraventricular hemorrhage and ventriculomegaly. The Developmental Epidemiology Network. J Pediatr. 1999 May; 134(5):539-46. View abstract
  239. Characteristics of cranial ultrasound white-matter echolucencies that predict disability: a review. Dev Med Child Neurol. 1999 Feb; 41(2):136-9. View abstract
  240. Prognostic limitations of the Daumas-Duport grading scheme in childhood supratentorial astroglial tumors. J Neuropathol Exp Neurol. 1998 Nov; 57(11):1035-40. View abstract
  241. Groups of histopathologic abnormalities in brains of very low birthweight infants. J Neuropathol Exp Neurol. 1998 Nov; 57(11):1026-34. View abstract
  242. Infection remote from the brain, neonatal white matter damage, and cerebral palsy in the preterm infant. Semin Pediatr Neurol. 1998 Sep; 5(3):190-201. View abstract
  243. Heavy caffeine consumption in pregnancy, smoking, and sudden infant death syndrome. Arch Dis Child. 1998 Sep; 79(3):291. View abstract
  244. Clusters of histologic characteristics in children with infratentorial neuroglial tumors. The Childhood Brain Tumor Consortium. J Neurooncol. 1998 Aug; 39(1):51-63. View abstract
  245. Is some white matter damage in preterm neonates induced by a human pestivirus? Arch Dis Child Fetal Neonatal Ed. 1998 May; 78(3):F230-1. View abstract
  246. Variation in use of corticosteroids among infants < or = 1,500 grams across hospitals in three states. J Matern Fetal Med. 1998 May-Jun; 7(3):137-41. View abstract
  247. Does prepregnancy bacterial vaginosis increase a mother's risk of having a preterm infant with cerebral palsy? Dev Med Child Neurol. 1997 Dec; 39(12):836-40. View abstract
  248. Thyroxine values from newborn screening of 919 infants born before 29 weeks' gestation. Am J Public Health. 1997 Oct; 87(10):1693-7. View abstract
  249. Quantitative histologic factors for grouping childhood infratentorial neuroglial tumors. Pediatr Pathol Lab Med. 1997 Sep-Oct; 17(5):809-34. View abstract
  250. Prognosis for children with supratentorial neuroglial tumors. Pediatr Pathol Lab Med. 1997 Sep-Oct; 17(5):755-67. View abstract
  251. Predictors of ventriculoperitoneal shunt among babies with intraventricular hemorrhage. J Child Neurol. 1997 Sep; 12(6):381-6. View abstract
  252. Quantitative histologic factors for grouping childhood supratentorial neuroglial tumors. Pediatr Pathol Lab Med. 1997 Sep-Oct; 17(5):729-54. View abstract
  253. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res. 1997 Jul; 42(1):1-8. View abstract
  254. Neonatal risk factors for cerebral palsy in very preterm babies. Time oriented analyses of risk are useful. BMJ. 1997 May 31; 314(7094):1624. View abstract
  255. Frequency of neuropathological abnormalities in very low birth weight infants. J Neuropathol Exp Neurol. 1997 May; 56(5):472-8. View abstract
  256. Prenatal magnesium sulfate exposure and risk of cerebral palsy. JAMA. 1997 Apr 02; 277(13):1033-4. View abstract
  257. Maternal receipt of magnesium sulfate does not seem to reduce the risk of neonatal white matter damage. Pediatrics. 1997 Apr; 99(4):E2. View abstract
  258. Duration of transient hyperechoic images of white matter in very-low-birthweight infants: a proposed classification. Dev Med Child Neurol. 1997 Jan; 39(1):2-5. View abstract
  259. Re: Effects of caffeine consumption on delayed conception. Am J Epidemiol. 1996 Oct 15; 144(8):800-1. View abstract
  260. Ventriculomegaly, delayed myelination, white matter hypoplasia, and "periventricular" leukomalacia: how are they related? Pediatr Neurol. 1996 Sep; 15(2):127-36. View abstract
  261. Survival of children with infratentorial neuroglial tumors. The Childhood Brain Tumor Consortium. Neurosurgery. 1996 Jul; 39(1):45-54; discussion 54-6. View abstract
  262. Maternal non-phenylketonuric mild hyperphenylalaninemia. Eur J Pediatr. 1996 Jul; 155 Suppl 1:S20-5. View abstract
  263. Persistent pulmonary hypertension of the newborn and smoking and aspirin and nonsteroidal antiinflammatory drug consumption during pregnancy. Pediatrics. 1996 May; 97(5):658-63. View abstract
  264. Coffee consumption and residual confounding. Epidemiology. 1996 Jan; 7(1):110-11. View abstract
  265. Ureaplasma urealyticum infection of the placenta in pregnancies that ended prematurely. Obstet Gynecol. 1996 Jan; 87(1):122-7. View abstract
  266. Age-related changes in diagnoses, histological features, and survival in children with brain tumors: 1930-1979. The Childhood Brain Tumor Consortium. Neurosurgery. 1995 Dec; 37(6):1056-68. View abstract
  267. Models of delayed recovery. J Child Neurol. 1995 Sep; 10(5):385-91. View abstract
  268. The perinatal paradox. Am J Public Health. 1995 Jul; 85(7):906-7. View abstract
  269. Hypocarbia before surfactant therapy appears to increase bronchopulmonary dysplasia risk in infants with respiratory distress syndrome. Arch Pediatr Adolesc Med. 1995 Jun; 149(6):617-22. View abstract
  270. Trans fatty acid and coronary disease: the debate continues. 1. The use of population attributable risk. Am J Public Health. 1995 Mar; 85(3):410; author reply 412-3. View abstract
  271. Maternal metabolic control and risk of microcephaly among infants of diabetic mothers. Diabetes Care. 1995 Feb; 18(2):166-9. View abstract
  272. Effect of maternal glucocorticoid exposure on risk of severe intraventricular hemorrhage in surfactant-treated preterm infants. J Pediatr. 1995 Feb; 126(2):272-9. View abstract
  273. Does coffee consumption increase the risk of reproductive adversities? J Am Med Womens Assoc (1972). 1995 Jan-Feb; 50(1):20-2. View abstract
  274. Histologic feature reliability in childhood neural tumors. Childhood Brain Tumor Consortium. J Neuropathol Exp Neurol. 1994 Nov; 53(6):559-71. View abstract
  275. Correlates of decaffeinated coffee choice. Epidemiology. 1994 Sep; 5(5):537-40. View abstract
  276. Pre- and postnatal lead exposure and behavior problems in school-aged children. Environ Res. 1994 Jul; 66(1):12-30. View abstract
  277. The role of family history in risk of childhood brain tumors. Cancer. 1994 Feb 15; 73(4):1302-11. View abstract
  278. Headache recurrence in pregnant women with migraine. Headache. 1994 Feb; 34(2):107-10. View abstract
  279. Cerebral palsy. N Engl J Med. 1994 Jan 20; 330(3):188-95. View abstract
  280. Children with hypoplastic enamel defects of primary incisors are not at increased risk of learning-problem syndromes. ASDC J Dent Child. 1994 Jan-Feb; 61(1):35-8. View abstract
  281. Ventricular dilatation in preterm infants. Pediatr Neurol. 1993 Nov-Dec; 9(6):498. View abstract
  282. Relationships between serial blood lead levels and exfoliated tooth dentin lead levels: models of tooth lead kinetics. Calcif Tissue Int. 1993 Nov; 53(5):338-41. View abstract
  283. Antenatal corticosteroids appear to reduce the risk of postnatal germinal matrix hemorrhage in intubated low birth weight newborns. Pediatrics. 1993 Jun; 91(6):1083-8. View abstract
  284. Preterm birth and cerebral palsy: is tumor necrosis factor the missing link? Dev Med Child Neurol. 1993 Jun; 35(6):553-8. View abstract
  285. Parental smoking and risk of childhood brain tumors. Am J Epidemiol. 1993 Mar 15; 137(6):620-8. View abstract
  286. The Boston Teacher Questionnaire. 1. Definition of syndromes. J Child Neurol. 1993 Jan; 8(1):43-53. View abstract
  287. The Boston Teacher Questionnaire. 2. Assessments of validity. J Child Neurol. 1993 Jan; 8(1):54-63. View abstract
  288. Pre- and postnatal low-level lead exposure and children's dysfunction in school. Environ Res. 1993 Jan; 60(1):30-43. View abstract
  289. The Boston Teacher Questionnaire. 3. A reassessment. J Child Neurol. 1993 Jan; 8(1):64-72. View abstract
  290. Behavioral correlates of caffeine consumption by children. Clin Pediatr (Phila). 1992 Dec; 31(12):742-50. View abstract
  291. Childhood brain tumors that occupy more than one compartment at presentation. Multiple compartment tumors. J Neurooncol. 1992 Sep; 14(1):45-56. View abstract
  292. Temporal trends among childhood brain tumor biopsies. The Childhood Brain Tumor Consortium. J Neurooncol. 1992 Jun; 13(2):137-49. View abstract
  293. Rate of bronchopulmonary dysplasia as a function of neonatal intensive care practices. J Pediatr. 1992 Jun; 120(6):938-46. View abstract
  294. Antecedents and correlates of hypoplastic enamel defects of primary incisors. Pediatr Dent. 1992 May-Jun; 14(3):158-66. View abstract
  295. Pre-natal blood lead levels and learning difficulties in children: an analysis of non-randomly missing categorical data. Stat Med. 1992 Apr; 11(6):799-811. View abstract
  296. Problems with definitions and classifications of newborn encephalopathy. Pediatr Neurol. 1992 Mar-Apr; 8(2):85-90. View abstract
  297. Epidemiology of seizures in children with brain tumors. The Childhood Brain Tumor Consortium. J Neurooncol. 1992 Jan; 12(1):53-68. View abstract
  298. Maternal toxemia is associated with reduced incidence of germinal matrix hemorrhage in premature babies. J Child Neurol. 1992 Jan; 7(1):70-6. View abstract
  299. Preterm infants born to women who had an elevated prepregnancy body mass index appear to be at increased risk of germinal matrix hemorrhage. Am J Hum Biol. 1992; 4(5):567-572. View abstract
  300. Study on PMS and caffeine consumption flawed. Am J Public Health. 1991 Dec; 81(12):1673-5. View abstract
  301. How much of neonatal encephalopathy is due to birth asphyxia? Am J Dis Child. 1991 Nov; 145(11):1325-31. View abstract
  302. Lead levels among various deciduous tooth types. Bull Environ Contam Toxicol. 1991 Oct; 47(4):602-8. View abstract
  303. Macroscopic enamel defects of primary anterior teeth--types, prevalence, and distribution. Pediatr Dent. 1991 Jul-Aug; 13(4):208-16. View abstract
  304. Weight gain and maturity in fetuses exposed to low levels of lead. Environ Res. 1991 Apr; 54(2):151-8. View abstract
  305. Low-level lead exposure and children's cognitive function in the preschool years. Pediatrics. 1991 Feb; 87(2):219-27. View abstract
  306. The epidemiology of germinal matrix hemorrhage during the first half-day of life. Dev Med Child Neurol. 1991 Feb; 33(2):138-45. View abstract
  307. Labor and delivery characteristics and the risk of germinal matrix hemorrhage in low birth weight infants. J Child Neurol. 1991 Jan; 6(1):35-40. View abstract
  308. Antecedents and correlates of improved cognitive performance in children exposed in utero to low levels of lead. Environ Health Perspect. 1990 Nov; 89:5-11. View abstract
  309. Asthma and eczema in children born to women with migraine. Arch Neurol. 1990 Nov; 47(11):1227-30. View abstract
  310. White matter damage in preterm newborns--an epidemiologic perspective. Early Hum Dev. 1990 Oct; 24(1):1-22. View abstract
  311. Early and late germinal matrix hemorrhage may have different antecedents. Eur J Obstet Gynecol Reprod Biol. 1990 Oct; 37(1):47-54. View abstract
  312. Maternal glucocorticoid therapy and reduced risk of bronchopulmonary dysplasia. Pediatrics. 1990 Sep; 86(3):331-6. View abstract
  313. Childhood brain tumor: presentation at younger age is associated with a family tumor history. Cancer Causes Control. 1990 Jul; 1(1):75-9. View abstract
  314. Educational infant care and the public health. Am J Public Health. 1990 Jul; 80(7):790-1. View abstract
  315. Periventricular-intraventricular hemorrhage, sonographic localization, phenobarbital, and motor abnormalities in low birth weight infants. Pediatrics. 1990 Jun; 85(6):1027-33. View abstract
  316. Hydration during the first days of life and the risk of bronchopulmonary dysplasia in low birth weight infants. J Pediatr. 1990 Jun; 116(6):942-9. View abstract
  317. Methylxanthine consumption and the risk of ovarian malignancy. Cancer Lett. 1990 May 30; 51(2):91-101. View abstract
  318. Maternal theophylline consumption and the risk of stillbirth. Chest. 1990 May; 97(5):1266-7. View abstract
  319. Lead and childhood propensity to infectious and allergic disorders: is there an association? Bull Environ Contam Toxicol. 1990 May; 44(5):657-60. View abstract
  320. Epilepsy and suicide. Arch Neurol. 1990 Apr; 47(4):381-2. View abstract
  321. The long-term effects of exposure to low doses of lead in childhood. An 11-year follow-up report. N Engl J Med. 1990 Jan 11; 322(2):83-8. View abstract
  322. File drawers, p values and efficacy of drugs. J Clin Epidemiol. 1990; 43(9):1012-4. View abstract
  323. Respiratory distress syndrome and intracranial hemorrhage: cause or association? Inferences from surfactant clinical trials. Pediatrics. 1989 Nov; 84(5):915-22. View abstract
  324. Blood lead--tooth lead relationship among Boston children. Bull Environ Contam Toxicol. 1989 Oct; 43(4):485-92. View abstract
  325. Neurologic sequelae of pertussis immunization--1989. J Child Neurol. 1989 Oct; 4(4):311-4. View abstract
  326. Problems in estimating the prevalence of epilepsy in children: the yield from different sources of information. Paediatr Perinat Epidemiol. 1989 Oct; 3(4):386-401. View abstract
  327. Lead, IQ and social class. Int J Epidemiol. 1989 Mar; 18(1):180-5. View abstract
  328. Prevalence of the epilepsies in children and adolescents. Epilepsia. 1989 Jan-Feb; 30(1):94-106. View abstract
  329. Low-level lead exposure, social class, and infant development. Neurotoxicol Teratol. 1988 Nov-Dec; 10(6):497-503. View abstract
  330. Hemorrhage, phenobarbital, and fluctuating cerebral blood flow velocity in the neonate. Pediatrics. 1988 Oct; 82(4):548-53. View abstract
  331. Maternal toxemia and neonatal germinal matrix hemorrhage in intubated infants less than 1751 g. Obstet Gynecol. 1988 Oct; 72(4):571-6. View abstract
  332. Etiologic heterogeneity of intracranial hemorrhages in preterm newborns. Pediatr Neurol. 1988 Sep-Oct; 4(5):274-8. View abstract
  333. Bilirubin, intraventricular hemorrhage, and phenobarbital in very low birth weight babies. Pediatrics. 1988 Sep; 82(3):350-4. View abstract
  334. Interobserver variability in the ILAE classification of seizures in childhood. Epilepsia. 1988 Mar-Apr; 29(2):123-8. View abstract
  335. Relation between age, education, and time to respond to questions in a computer-based medical interview. Comput Biomed Res. 1988 Feb; 21(1):78-84. View abstract
  336. Caffeine consumption and the risk of reproductive hazards. J Reprod Med. 1988 Feb; 33(2):175-8. View abstract
  337. Arterial blood gas derangements associated with death and intracranial hemorrhage in premature babies. J Perinatol. 1988; 8(4):336-41. View abstract
  338. Single-cause attribution. Dev Med Child Neurol. 1987 Dec; 29(6):805-7. View abstract
  339. Pregnancy hypertension, blood pressure during labor, and blood lead levels. Hypertension. 1987 Oct; 10(4):447-51. View abstract
  340. Migraine and other diseases in women of reproductive age. The influence of smoking on observed associations. Arch Neurol. 1987 Oct; 44(10):1024-8. View abstract
  341. The prophylactic clinical trial as a epidemiologic resource. Control Clin Trials. 1987 Sep; 8(3):243-54. View abstract
  342. Respiratory complications in low-birth-weight infants who received phenobarbital. Am J Dis Child. 1987 Sep; 141(9):996-9. View abstract
  343. Longitudinal analyses of prenatal and postnatal lead exposure and early cognitive development. N Engl J Med. 1987 Apr 23; 316(17):1037-43. View abstract
  344. Perinatal asphyxia. Pediatr Neurol. 1987 Mar-Apr; 3(2):123. View abstract
  345. Dyslipoproteinemia and migraine. Pediatrics. 1986 Nov; 78(5):956-7. View abstract
  346. Do learning handicaps and headache cluster? J Child Neurol. 1986 Oct; 1(4):372-7. View abstract
  347. Childhood brain tumors and paternal occupation in the aerospace industry. J Natl Cancer Inst. 1986 Jul; 77(1):17-9. View abstract
  348. Correlates of low-level lead exposure in urban children at 2 years of age. Pediatrics. 1986 Jun; 77(6):826-33. View abstract
  349. Occurrence of elevated protoporphyrin levels in relation to lead burden in infants. Environ Res. 1986 Apr; 39(2):253-7. View abstract
  350. Neonatal intracranial hemorrhage and phenobarbital. Pediatrics. 1986 Apr; 77(4):443-50. View abstract
  351. Low-level lead exposure and infant development in the first year. Neurobehav Toxicol Teratol. 1986 Mar-Apr; 8(2):151-61. View abstract
  352. Ultrasound scans of brain in pre-term infants. Lancet. 1986 Jan 18; 1(8473):161. View abstract
  353. In-home versus clinic-based services for the developmentally disabled child: who is the primary client--parent or child? Soc Work Health Care. 1986; 11(3):75-88. View abstract
  354. Consequences of unremitting middle-ear infection in early life. N Engl J Med. 1985 Nov 21; 313(21):1353-4. View abstract
  355. Methodological issues in modeling the relationship between low-level lead exposure and infant development: examples from the Boston Lead Study. Environ Res. 1985 Oct; 38(1):119-29. View abstract
  356. Environmental correlates of infant blood lead levels in Boston. Environ Res. 1985 Oct; 38(1):96-107. View abstract
  357. Lead in milk and infant blood: a dose-response model. Arch Environ Health. 1985 Sep-Oct; 40(5):283-6. View abstract
  358. Perinatal factors and seizure disorders: an epidemiologic review. Epilepsia. 1985 Jul-Aug; 26(4):287-98. View abstract
  359. Home refinishing, lead paint, and infant blood lead levels. Am J Public Health. 1985 Apr; 75(4):403-4. View abstract
  360. Pre- and postnatal bacterial infections as risk factors of the perinatal leucoencephalopathies. Prog Clin Biol Res. 1985; 163B:75-9. View abstract
  361. Posttraumatic seizures: an assessment of the epidemiologic literature. Cent Nerv Syst Trauma. 1985; 2(1):33-43. View abstract
  362. Early sensory-motor development and prenatal exposure to lead. Neurobehav Toxicol Teratol. 1984 Sep-Oct; 6(5):387-402. View abstract
  363. To what extent does food sensitivity contribute to headache recurrence? Dev Med Child Neurol. 1984 Aug; 26(4):542-5. View abstract
  364. Acquired perinatal leukoencephalopathy. Ann Neurol. 1984 Jul; 16(1):1-8. View abstract
  365. Age-related headache characteristics. Arch Neurol. 1984 Jul; 41(7):762-4. View abstract
  366. A computerized behavioral assessment for children with headaches. Headache. 1984 Jul; 24(2):182-5. View abstract
  367. The relationship between prenatal exposure to lead and congenital anomalies. JAMA. 1984 Jun 08; 251(22):2956-9. View abstract
  368. Epidemiology: use and utility in the process. Fundam Appl Toxicol. 1984 Jun; 4(3 Pt 2):S357-66. View abstract
  369. Variability of blood lead concentrations during infancy. Arch Environ Health. 1984 Mar-Apr; 39(2):74-7. View abstract
  370. Childhood brain tumor update. Hum Pathol. 1983 Oct; 14(10):834-45. View abstract
  371. Lead-associated intellectual deficit. N Engl J Med. 1982 Feb 11; 306(6):367. View abstract
  372. Does lead at low dose affect intelligence in children? Pediatrics. 1981 Dec; 68(6):894-6. View abstract
  373. Periventricular leukomalacia. Arch Neurol. 1981 Jun; 38(6):398. View abstract
  374. Use of a computerized data base in a headache clinic. Headache. 1981 Mar; 21(2):72-4. View abstract
  375. Methodological issues in the epidemiology of seizure disorders in children. Epidemiol Rev. 1981; 3:67-89. View abstract
  376. A headache chronicle: the daily recording of headaches and their correlates. J Chronic Dis. 1981; 34(9-10):481-6. View abstract
  377. The relationship of headache occurrence to barometric pressure. Int J Biometeorol. 1980 Sep; 24(3):263-9. View abstract
  378. Otitis media and learning disorders. J Dev Behav Pediatr. 1980 Jun; 1(2):58-63. View abstract
  379. Periventricular hemorrhage in the newborn. Neurology. 1980 Jun; 30(6):677-9. View abstract
  380. A computer-based headache interview: acceptance by patients and physicians. Headache. 1980 Mar; 20(2):85-9. View abstract
  381. A probability model of headache recurrence. J Chronic Dis. 1980; 33(7):407-12. View abstract
  382. Primary care approaches to developmental disabilities. Pediatrics. 1979 Oct; 64(4):506-14. View abstract
  383. Maternal urinary-tract infections and fetal leukoencephalopathy. N Engl J Med. 1979 Sep 20; 301(12):661. View abstract
  384. Lead and neurobehavioural deficit in children. Lancet. 1979 Jul 14; 2(8133):104. View abstract
  385. Use of a self-administered questionnaire for detection of transient cerebral ischemic attacks: I. Survey of elderly persons living in retirement facilities. Ann Neurol. 1979 Jul; 6(1):40-6. View abstract
  386. Headache rounds--acquired migraine. Headache. 1979 Jul; 19(5):254-6. View abstract
  387. Training in developmental pediatrics. How practitioners perceive the gap. Am J Dis Child. 1979 Jul; 133(7):709-12. View abstract
  388. Deficits in psychologic and classroom performance of children with elevated dentine lead levels. N Engl J Med. 1979 Mar 29; 300(13):689-95. View abstract
  389. Neurologic effects of exposure to lead. J Pediatr. 1979 Mar; 94(3):505-6. View abstract
  390. Seasonal variation in the birth of left-handed schoolgirls. Arch Neurol. 1979 Feb; 36(2):115-6. View abstract
  391. Epidemiology of periventricular leukomalacia. Trans Am Neurol Assoc. 1979; 104:168-72. View abstract
  392. The thymus in infants with perinatal telencephalic leukoencephalopathy. Arch Neurol. 1978 Jun; 35(6):377-81. View abstract
  393. Densely cellular cerebellar tumors in children. Trans Am Neurol Assoc. 1978; 103:265-8. View abstract
  394. Survival status of children with cerebellar gliomas. J Neurosurg. 1978 Jan; 48(1):29-33. View abstract
  395. Epidemiology of headache. Adv Neurol. 1978; 19:341-53. View abstract
  396. The influence of route of delivery and hyaline membranes on the risk of neonatal intracranial hemorrhages. Ann Neurol. 1977 Dec; 2(6):451-4. View abstract
  397. Limitations of autopsy data in relating neonatal intracranial hemorrhage to buffer therapy. Hum Pathol. 1977 Nov; 8(6):599-601. View abstract
  398. Secular trends of cerebellar gliomas in children. J Natl Cancer Inst. 1977 Apr; 58(4):839-43. View abstract
  399. Cerebellar gliomas in children. J Natl Cancer Inst. 1977 Apr; 58(4):833-8. View abstract
  400. Methylphenidate therapy for inattentiveness in selected school children. Ann Neurol. 1977 Mar; 1(3):307-8. View abstract
  401. Histologic features and observational variation in cerebellar gliomas in children. J Natl Cancer Inst. 1977 Feb; 58(2):175-81. View abstract
  402. Risk factors of delayed myelination in the newborn. Trans Am Neurol Assoc. 1977; 102:39-41. View abstract
  403. Multivariate analysis of risk of perinatal telencephalic leucoencephalopathy. Am J Epidemiol. 1976 Dec; 104(6):621-6. View abstract
  404. Violence. Headache. 1976 Nov; 16(5):203-9. View abstract
  405. Letter: Birth order and left-handedness. Arch Neurol. 1976 Sep; 33(9):664. View abstract
  406. Reaction times and Digit Symbol Test scores of girls identified as daydreamers by their teachers. Percept Mot Skills. 1976 Aug; 43(1):239-44. View abstract
  407. Endotoxin leucoencephalopathy in the telencephalon of the newborn kitten. J Neurol Sci. 1976 Feb; 27(2):183-91. View abstract
  408. Cesarian section and the risk of neonatal intracranial hemorrhage. Trans Am Neurol Assoc. 1976; 101:121-4. View abstract
  409. Severe headache after carotid endarterectomy. Headache. 1975 Oct; 15(3):207-10. View abstract
  410. Contraction stress test for antepartum fetal evaluation. Obstet Gynecol. 1975 Apr; 45(4):433-8. View abstract
  411. "Headache rounds": post carotid-endarterectomy "hemicrania". Headache. 1975 Apr; 15(1):13-7. View abstract
  412. Letter: Intracranial hemorrhage in infants. N Engl J Med. 1974 Nov 14; 291(20):1088. View abstract
  413. Astrocytosis without globules in infant cerebral white matter. An epidemiologic study. J Neurol Sci. 1974 Jul; 22(3):329-40. View abstract
  414. Morphologic abnormalities in human infant cerebral white matter related to gestational and postnatal age. Pediatr Res. 1974 Jul; 8(7):718-20. View abstract
  415. Vascular diseases, mortality, and migraine in the parents of migraine patients. Neurology. 1974 Jul; 24(7):669-72. View abstract
  416. Letter: Definitions of attributable risk. Am J Epidemiol. 1973 Sep; 98(3):231. View abstract
  417. Are hypertrophic astrocytes a sufficient criterion of perinatal telencephalic leucoencephalopathy? J Neurol Neurosurg Psychiatry. 1973 Jun; 36(3):383-8. View abstract
  418. An epidemiologic study of perinatal telencephalic leucoencephalopathy in an autopsy population. J Neurol Sci. 1973 Jan; 18(1):53-66. View abstract
  419. Neurologic manifestations of embryonal rhabdomyosarcoma of the middle ear cleft. J Pediatr. 1972 Apr; 80(4):596-602. View abstract
  420. Morphologic correlates of age at death of infants with perinatal telencephalic leukoencephalopathy. Am J Pathol. 1971 Nov; 65(2):303-9. View abstract
  421. Custering of the morphological components of perinatal telencephalic leucoencephalopathy. J Neurol Neurosurg Psychiatry. 1971 Oct; 34(5):642-5. View abstract
  422. Fatty-acid metabolism in migraine. Lancet. 1971 Jul 03; 2(7714):48. View abstract
  423. Neonatal white matter vulnerability: changes with time. Trans Am Neurol Assoc. 1971; 96:269-70. View abstract
  424. Migraine associated with hyper-pre-beta lipoproteinemia. Neurology. 1969 Oct; 19(10):963-6. View abstract
  425. Renal vein thrombectomy for the treatment of renal vein thrombosis associated with the neophrotic syndrome. J Urol. 1968 Jan; 99(1):1-13. View abstract